ARTICLE

FindCenter AddIcon

FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression

By Yasemin Saplakoglu — 2019

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

Read on www.livescience.com

FindCenter Post-Image
24:21

Amanda Feilding: The Beckley Foundation’s Program of Psychedelic Research

Psychedelics afford a unique opportunity to expand our understanding of consciousness and its altered states, to develop techniques for enhancing consciousness, and to uncover new avenues of treatment and improved therapeutic techniques.

FindCenter AddIcon
FindCenter Post-Image
01:11:17

Opening Plenary: Rick Doblin, Amanda Feilding & Beatriz Labate

Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.

FindCenter AddIcon

EXPLORE TOPIC

Psilocybin